Dosimetric Feasibility of Dose Escalation Using SBRT Boost for Stage III Non-Small Cell Lung Cancer

by Jaroslaw T. Hepel, Justin ePeter, Jessica R. Hiatt, Salil ePatel, Oluwademilade eOsibanjo, Howard eSafran, Bruce eCurran, Thomas eDiPetrillo
Published 2012-09-01

A phase I study of dasatinib with concurrent chemoradiation for stage III non small cell lung cancer (NSCLC)

by Howard eSafran, Thomas eDiPetrillo, Humera eKhurshid, Thomas eNg, Kalyan eMantripragada, Ariel eBirnbaum, David eBerz, Kathy eRadie-Keane, Kimberly ePerez, Maria eConstantinou, Denise eLuppe, Andrew eSchumacher, Kara eLeonard
Published 2012-05-01